A recent independent study conducted by IDK Germany shows that 98.8% of all results from VivaChek Ino blood glucose monitoring system are within ±15% or 15mg/dL (0.83 mmol/L) of the YSI plasma results, which is fully complying with the new EN ISO 15197:2015 standard.

Over and under estimation of glucose due to the hematocrit effect is a common source of error. Anemia falsely elevates while polycythemia and dehydration falsely depresses blood glucose values. The magnitude of this effect may vary by 4-30% for every 10% change I hematocrit, depending on the systems. According to the WHO, anemia affects about 24.8% of the population in the world, about 47.4% of pre-school children and 41.8% of pregnant women world-wide.

With the advanced Hematocrit Correction technology, the VivaChek Ino blood glucose monitoring system could be used for testing patients with hematocrit level within 20-70%, including neonates with very high hematocrit level, as well as anemia people and pregnant women with very low hematocrit level.

With Glucowell Diabetes Management APP,
Glucose results from Vivachek Ino Sound meter can be sent automatically to your smart devices, then you can review how your blood glucose level is affected by food, medications and activates on one chart. You could manage your blood glucose better.